December 5 Product: Merus Bizengri Indication: Pancreatic adenocarcinoma and non-small cell lung cancer with NGR1 mutations Merus bispecific antibody zenocutuzumab on Wednesday became the first and only therapy for advanced unresectable or metastatic pancreatic adenocarcinoma and NSCLC with NRG1 gene fusions
"DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status"
In February, the government unveiled TrumpRx, a web portal directing patients to lower-price versions of some drugs, with some terms and conditions
Semaglutide works by mimicking just one hormone, GLP-1, to achieve similar effects
Yes, many patients experience mild side effects when their dose increases, but these are usually less intense than the initial adjustment and resolve fasteroften within 37 days